Une charge virale diminuÃ©e de 99% ? La plitidepsine fait renaÃ®tre l'espoir en Espagne

lababouche
Published on Mar 12, 2022
27-01-2021 Alors qu'une pÃ©nurie des doses commence Ã se faire sentir, un laboratoire espagnol a rÃ©cemment annoncÃ© qu'un nouveau mÃ©dicament, la plitidepsine, rÃ©duisait la charge virale du Covid-19 de 99%. Le laboratoire attend dÃ©sormais les autorisations nÃ©cessaires pour entamer sa phase finale d'essais cliniques.
Abonnez-vous Ã la chaÃ®ne YouTube de RT France : https://www.youtube.com/rtenfrancais
RT en franÃ§ais : http://rtfrance.tv
Facebook : https://www.facebook.com/RTFrance
Twitter : https://twitter.com/rtenfrancais
Instagram : https://www.instagram.com/rtfrance/
Lien vers le site web de balance la babouche
https://balancemababouche.com
Le site web des gardiens du vivant
https://desgardiens.com

Add to

Please Sign In or Create Account to use this feature!

Flag Video

Please Sign In or Create Account to use this feature!

Rate video

Please Sign In or Create Account to use this feature!

Rate video

Please Sign In or Create Account to use this feature!

DISCLAIMER

The content presented in this stream and/or video may be satirical in nature for entertainment purposes. It may contain realistic scenarios that may include themes of racism, anti-semitism, anti-LGBT sentiment and even elements such as death threats, all purely in the context of parody. In addition, this content may depict or refer to acts of violence in a satirical manner. Shock factor is a common and deliberate element used in these displays to emphasise the satirical message. By continuing to view this content, you acknowledge that you understand the satirical nature of this content, including the depiction of violence and the use of shock factor, and agree that you will not use or interpret this content outside of its intended context. Please remember that humour and satire are complex; they are not intended to belittle or demean, but to engage and challenge social norms through exaggeration. If you have any concerns about content, please feel free to engage in constructive dialogue or report issues to GTV staff.